Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais Opções

Total de passivos e patrimônio líquido de Amylyx Pharmaceuticals, Inc..

Dados anuais

2020

2021

2022

2023

2024

‪0,00‬

‪‪150,00 M‬‬

‪‪300,00 M‬‬

‪‪450,00 M‬‬

‪‪600,00 M‬‬

Período

Valor

Variação

Variação %

2024

‪‪193,63 M‬‬

‪‪−323,82 M‬‬

‪−62,58‬%

2023

‪‪517,45 M‬‬

+‪‪126,00 M‬‬

+‪32,19‬%

2022

‪‪391,45 M‬‬

+‪‪285,84 M‬‬

+‪270,64‬%

2021

‪‪105,61 M‬‬

+‪‪91,51 M‬‬

+‪648,82‬%

2020

‪‪14,10 M‬‬

+‪‪10,88 M‬‬

+‪338,01‬%

Dados trimestrais

Q1 '21

Q2 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0,00‬

‪‪150,00 M‬‬

‪‪300,00 M‬‬

‪‪450,00 M‬‬

‪‪600,00 M‬‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪193,63 M‬‬

‪‪−57,08 M‬‬

‪−22,77‬%

Q3 '24

‪‪250,71 M‬‬

‪‪−81,45 M‬‬

‪−24,52‬%

Q2 '24

‪‪332,16 M‬‬

‪‪−85,30 M‬‬

‪−20,43‬%

Q1 '24

‪‪417,46 M‬‬

‪‪−100,00 M‬‬

‪−19,32‬%

Q4 '23

‪‪517,45 M‬‬

+‪‪50,87 M‬‬

+‪10,90‬%

Q3 '23

‪‪466,58 M‬‬

+‪‪13,00 M‬‬

+‪2,87‬%

Q2 '23

‪‪453,59 M‬‬

+‪‪45,63 M‬‬

+‪11,18‬%

Q1 '23

‪‪407,96 M‬‬

+‪‪16,50 M‬‬

+‪4,22‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q2 '21

Q1 '21